AR039167A1 - Metodo para tratar la hipertension ocular y glaucoma - Google Patents
Metodo para tratar la hipertension ocular y glaucomaInfo
- Publication number
- AR039167A1 AR039167A1 ARP030101075A ARP030101075A AR039167A1 AR 039167 A1 AR039167 A1 AR 039167A1 AR P030101075 A ARP030101075 A AR P030101075A AR P030101075 A ARP030101075 A AR P030101075A AR 039167 A1 AR039167 A1 AR 039167A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydroxy
- aliphatic hydrocarbon
- alkyl
- glaucoma
- keto
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 3
- 206010030043 Ocular hypertension Diseases 0.000 title abstract 3
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229940054534 ophthalmic solution Drugs 0.000 abstract 2
- 239000002997 ophthalmic solution Substances 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36772202P | 2002-03-28 | 2002-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR039167A1 true AR039167A1 (es) | 2005-02-09 |
Family
ID=28675389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101075A AR039167A1 (es) | 2002-03-28 | 2003-03-27 | Metodo para tratar la hipertension ocular y glaucoma |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030220396A1 (https=) |
| JP (1) | JP2005519978A (https=) |
| AR (1) | AR039167A1 (https=) |
| AU (1) | AU2003215820A1 (https=) |
| TW (1) | TW200400039A (https=) |
| WO (1) | WO2003082257A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR043161A1 (es) * | 2003-02-14 | 2005-07-20 | Sucampo Pharmaceuticals Inc | Composicion oftalmica para tratar hipertension ocular y glaucoma |
| WO2012108489A1 (ja) * | 2011-02-10 | 2012-08-16 | 参天製薬株式会社 | 親水性薬物の薬物移行性を改善した水性組成物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166178B1 (en) * | 1987-09-18 | 1998-07-21 | R Tech Ueno Ltd | Ocular hypotensive agents |
| US5151444B1 (en) * | 1987-09-18 | 1999-07-06 | R Tech Ueno Ltd | Ocular hypotensive agents |
| US5212200A (en) * | 1987-09-18 | 1993-05-18 | R-Tech Ueno, Ltd. | Ocular hypotensive agents |
| US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| DE68928551T2 (de) * | 1988-10-01 | 1998-04-23 | Ueno Seiyaku Oyo Kenkyujo Kk | Oculare hypotensive Mittel |
| ES2084771T3 (es) * | 1990-05-22 | 1996-05-16 | R Tech Ueno Ltd | Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica. |
| US5175189A (en) * | 1990-05-22 | 1992-12-29 | K.K. Ueno Seiyaku Oyo Kenkyujo | Treatment of ocular hypertension with a synergistic combination for ophthalmic use |
| AU687906B2 (en) * | 1993-12-15 | 1998-03-05 | Alcon Laboratories, Inc. | Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension |
| ATE326972T1 (de) * | 1997-10-13 | 2006-06-15 | R Tech Ueno Ltd | Heilende zusammensetzung für intraokulare hypertension oder glaukom |
| EP1069913B1 (en) * | 1998-04-07 | 2003-07-23 | Alcon Laboratories, Inc. | Gelling ophthalmic compositions containing xanthan gum |
| CA2402597C (en) * | 2000-03-16 | 2011-04-26 | Sucampo Ag | Composition for use in treatment of ocular hypertension and glaucoma |
| US6458836B1 (en) * | 2000-03-16 | 2002-10-01 | Sucampo, A.G. | Treatment of ocular hypertension and glaucoma |
| US20020035148A1 (en) * | 2000-07-20 | 2002-03-21 | Ryuji Ueno | Treatment of ocular hypertension |
| US6414021B1 (en) * | 2000-08-25 | 2002-07-02 | Sucampo Ag | Control of intraocular pressure during surgery |
| WO2002092098A1 (en) * | 2001-05-14 | 2002-11-21 | Sucampo Ag | Method for treating ocular hypertension and glaucoma |
| CA2454422A1 (en) * | 2001-07-31 | 2003-02-13 | Ryuji Ueno | Treatment of ocular hypertension and glaucoma |
| AR036276A1 (es) * | 2001-08-23 | 2004-08-25 | Sucampo Ag | Uso de un compuesto 15-ceto-prostaglandina para el tratamiento de hipertension ocular y glaucoma |
-
2003
- 2003-03-26 AU AU2003215820A patent/AU2003215820A1/en not_active Abandoned
- 2003-03-26 WO PCT/IB2003/001181 patent/WO2003082257A2/en not_active Ceased
- 2003-03-26 JP JP2003579795A patent/JP2005519978A/ja not_active Withdrawn
- 2003-03-27 AR ARP030101075A patent/AR039167A1/es unknown
- 2003-03-27 US US10/397,243 patent/US20030220396A1/en not_active Abandoned
- 2003-03-27 TW TW092106881A patent/TW200400039A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005519978A (ja) | 2005-07-07 |
| WO2003082257A3 (en) | 2003-12-24 |
| US20030220396A1 (en) | 2003-11-27 |
| WO2003082257A2 (en) | 2003-10-09 |
| AU2003215820A8 (en) | 2003-10-13 |
| AU2003215820A1 (en) | 2003-10-13 |
| TW200400039A (en) | 2004-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR120961A2 (es) | Método y composición para tratar hipertensión ocular y glaucoma | |
| ES2168357T3 (es) | Agonistas del receptor ep2 como agentes para disminuir la presion intraocular. | |
| ES2092316T3 (es) | Agentes antianginosos de purinona. | |
| ES2071919T3 (es) | Agentes antianginosos de pirazolopirimidina. | |
| ECSP056020A (es) | Inhibidores del factor inhibidor de la migración de los macrofagos y metodos para su identificacion | |
| UY39559A (es) | Compuestos y su uso | |
| PE20020637A1 (es) | Derivados de 5-oxo-pirrolidina como agonistas de prostaglandinas | |
| ES2183905T3 (es) | Inhibidores de metaloproteasa de matriz. | |
| CR7880A (es) | Derivados sustituidos de pirrolo-pirazol como inhibidores de quinasa | |
| AR078461A1 (es) | Inhibidores macrociclicos de la replicacion de virus de la hepatitis c | |
| CA2444103A1 (en) | Composition for treating drug-induced constipation with 15-keto-prostaglandins | |
| CO5590916A2 (es) | Dicetopiperacinas sustituidas como antagonistas de oxitocina | |
| RU2012119778A (ru) | Водная композиция | |
| RU2420291C3 (ru) | Состав в мягкой желатиновой капсуле | |
| AR033147A1 (es) | Compuestos de amida. | |
| PE20080378A1 (es) | Derivados tiofeno-pirazolalcanamida con actividad sobre los receptores ampa | |
| CO6150181A2 (es) | Compuesto 6-(bencilo sustituido con heterociclo)-4-oxoquinolina y su uso como inhibidor de integrasa vih | |
| AR042670A1 (es) | Uso del abridor del canal de cloruro para preparar un compuesto farmaceutico para tratar el malestar abdominal | |
| AR039167A1 (es) | Metodo para tratar la hipertension ocular y glaucoma | |
| AR030277A1 (es) | Composicion promotora de la secrecion biliar y uso de 15-ceto-prostaglandina para producirla | |
| AR035242A1 (es) | Uso de un lipido bioactivo halogenadopara preparar una composicion catartica y compuesto lipido bioactivo halogenado | |
| CR20120360A (es) | Combinación triple disminuir la presión intraocular | |
| IS6449A (is) | Aðferð til framleiðslu á 5-sýanóþalíði | |
| CA2502439A1 (en) | Prostaglandin compounds for the treatment of obesity | |
| AR041080A1 (es) | Compuestos de 5- croman- 5- il- etilamina substituidos y su uso para el tratamiento de glaucoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |